Found: 6
Select item for more details and to access through your institution.
An open-label multiyear study of sargramostim-treated Parkinson's disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00361-1
- By:
- Publication type:
- Article
Persistent EcoHIV infection induces nigral degeneration in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-intoxicated mice.
- Published in:
- Journal of NeuroVirology, 2018, v. 24, n. 4, p. 398, doi. 10.1007/s13365-018-0629-1
- By:
- Publication type:
- Article
Amyloid-β specific regulatory T cells attenuate Alzheimer's disease pathobiology in APP/PS1 mice.
- Published in:
- Molecular Neurodegeneration, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13024-023-00692-7
- By:
- Publication type:
- Article
A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson's Disease.
- Published in:
- Frontiers in Cellular Neuroscience, 2019, p. 1, doi. 10.3389/fncel.2019.00421
- By:
- Publication type:
- Article
CD4+ effector T cells accelerate Alzheimer's disease in mice.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Immune senescence in aged APP/PS1 mice.
- Published in:
- NeuroImmune Pharmacology & Therapeutics, 2023, v. 2, n. 3, p. 317, doi. 10.1515/nipt-2023-0015
- By:
- Publication type:
- Article